Literature DB >> 37048

The pH of sclerosing agents: a determinant of pleural symphysis.

S A Sahn, J T Good, D E Potts.   

Abstract

The rate of success in producing pleural symphysis with intrapleural instillation of sclerosing agents has been variable. Differences in the designs of studies probably account for some of the variability, but the reasons for the remainder are not clear. Since a low pH of the pleural fluid is associated with pleural adhesions and loculations, the pH of the commonly used solutions of sclerosing agents was determined, both in their usual concentrations and when diluted with large quantities of exudative pleural fluid. The buffered solution of tetracycline hydrochloride had the most acidic pH (2.0) and showed little change when diluted by pleural fluid. A 0.5 percent solution of sodium hydroxide had the highest pH (13.0). The remainder of the sclerosing solutions showed a range of pH from 4.3 to 8.7. Experimental and clinical experience suggests that tetracycline consistently has the highest rate of success in producing pleural symphysis. It appears that when proper technique is employed, the pH of the solution of the sclerosing agent is an important determinant of the production of pleural symphysis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 37048     DOI: 10.1378/chest.76.2.198

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Sodium hydroxide as a sclerosing agent in patients with neoplastic pleural effusion non-candidates for VATS: results of a minimally invasive protocol.

Authors:  Micaela Raices; Matías E Czerwonko; Agustin Dietrich; Alejandro Da Lozzo; Enrique Beveraggi; David Smith
Journal:  Updates Surg       Date:  2017-08-31

Review 2.  The differential diagnosis of pleural effusions.

Authors:  S A Sahn
Journal:  West J Med       Date:  1982-08

Review 3.  Diagnosis and treatment of malignant pleural effusion.

Authors:  F H Hausheer; J W Yarbro
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Cytostatic activity of oxidized tetracycline in vitro: relevance for the treatment of malignant effusions?

Authors:  C Sauter
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.